Alembic Pharmaceuticals forms bearish engulfing candle
Alembic Pharmaceuticals forms bearish engulfing candle

Alembic Pharmaceuticals forms bearish engulfing candle

Vinayak Gangule Article rating: 5.0

On Tuesday, the stock has formed a bearish engulfing candlestick pattern on the daily time frame. The bearish engulfing candlestick pattern is considered to be a bearish reversal pattern and usually, occurs at the top of an uptrend.

Day 2 of Sensex rally
Day 2 of Sensex rally

Day 2 of Sensex rally

Geyatee Deshpande Article rating: 4.0

Continuing the week with positive sentiments, Sensex on Tuesday rose by 1.17 per cent, higher than its previous close or by 371.44 points to be at the level of 32,114.52. Nifty gained by 1.06 per cent or 98.60 points to the reach level of 9,380.90.

Manappuram Finance gains on plans to raise up to Rs 500 crore
Manappuram Finance gains on plans to raise up to Rs 500 crore

Manappuram Finance gains on plans to raise up to Rs 500 crore

Avalokita Pandey Article rating: 3.7

The stock of Kerala-based gold loan provider-Manappuram Finance, gained more than nine per cent on Tuesday after the non-banking financial company (NBFC) informed that it is planning to raise capital up to Rs 500 crore.

IndusInd Bank Q4 profit down on higher provisions
IndusInd Bank Q4 profit down on higher provisions

IndusInd Bank Q4 profit down on higher provisions

Anthony Fernandes Article rating: 3.4

The shares of IndusInd Bank were trading in green by more than 10 per cent in the early trade on Tuesday after the company reported its March 2020 quarter numbers.

Axis Bank & Max Financial to form 30:70 JV in Max Life
Axis Bank & Max Financial to form 30:70 JV in Max Life

Axis Bank & Max Financial to form 30:70 JV in Max Life

Apurva Joshi Article rating: 5.0

The board of directors of Axis Bank has approved entering into an agreement with Max Financial Services Ltd (MFSL) to acquire 29 per cent stake in Max Life Insurance Company Ltd (Max Life).

Natco Pharma receives ANDA approval from USFDA
Natco Pharma receives ANDA approval from USFDA

Natco Pharma receives ANDA approval from USFDA

Amir Shaikh Article rating: 3.3

Natco Pharma today announced that it has received a final approval for its first supplemental abbreviated new drug application (ANDA) product from US Food & Drug Administration (USFDA)

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 4.8

The market opened in the green on April 28, 2020. The previous trading session witnessed the Sensex going up by 1.3 percent to end at 31,743 and the Nifty was up 1.4 percent to close at 9,282.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 4.0

The market opened in the green on April 28, 2020. The previous trading session witnessed the Sensex going up by 1.3 percent to end at 31,743 and the Nifty was up 1.4 percent to close at 9,282.
 

RSS
First22912292229322942296229822992300Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR